Summit Therapeutics
SMMT
#1265
Rank
NZ$24.09 B
Marketcap
$32.67
Share price
-7.38%
Change (1 day)
406.51%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2023 (TTM): -$2.70

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.90. In 2022 the company made an earnings per share (EPS) of -$0.86 an increase over its 2021 EPS that were of -$1.65.

EPS history for Summit Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.70212.68%
2022-$0.86-47.8%
2021-$1.65
2019-$0.37159.55%
2018-$0.14
2015-$1.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$13.50 365.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.19-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.72 97.49%๐Ÿ‡บ๐Ÿ‡ธ USA